NCT00887523

Brief Summary

84 patients with a cup size C or more will be randomized to receive intensity-modulated radiotherapy in supine or prone position.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 24, 2009

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2009

Completed
11.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2021

Completed
Last Updated

December 20, 2022

Status Verified

June 1, 2015

Enrollment Period

11.6 years

First QC Date

April 23, 2009

Last Update Submit

December 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • acute moist desquamation

    weekly during radiotherapy and 1 month after radiotherapy

Secondary Outcomes (7)

  • Acute skin toxicity other than moist desquamation

    weekly during radiotherapy and 1 month after radiotherapy

  • Late skin toxicity

    at 6, 12, 18 and 24 months after radiotherapy

  • skin and lung fibrosis assessed with computed tomography

    before radiotherapy and 1 month and 1 year after radiotherapy

  • Quality of life

    at 1 year and 2 years after radiotherpay

  • dose-volume parameters

    of planning

  • +2 more secondary outcomes

Study Arms (2)

1

EXPERIMENTAL

prone intensity-modulated radiotherapy

Behavioral: radiation in prone position

2

ACTIVE COMPARATOR

supine intensity-modulated radiotherapy

Behavioral: radiation in supine position

Interventions

radiation in prone position

1

radiation in supine position

2

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female patients
  • multidisciplinary decision of adjuvant whole-breast irradiation (WBI) after lumpectomy for breast cancer
  • minimum 18 years
  • informed consent obtained, signed and dated before specific protocol procedures

You may not qualify if:

  • mastectomy
  • need for axillary irradiation
  • bilateral breast irradiation
  • previous irradiation at the same time
  • mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study
  • patient unlikely to comply with the protocol; i.e. uncooperative attitude, inability to return for follow-up visits, and unlikely to complete the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, 9000, Belgium

Location

Related Publications (1)

  • Vakaet V, Van Hulle H, Vergotte M, Schoepen M, Deseyne P, Van Greveling A, Post G, Speleers B, Paelinck L, Monten C, De Neve W, Veldeman L. 5-Year Outcomes of a Randomized Trial Comparing Prone and Supine Whole Breast Irradiation in Large-Breasted Women. Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):766-771. doi: 10.1016/j.ijrobp.2021.01.026. Epub 2021 Jan 27.

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Interventions

RadiationProne PositionSupine Position

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Physical PhenomenaPostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Wilfried De Neve, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2009

First Posted

April 24, 2009

Study Start

July 1, 2009

Primary Completion

February 1, 2021

Study Completion

March 8, 2021

Last Updated

December 20, 2022

Record last verified: 2015-06

Locations